Article info

Download PDFPDF
Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity

Authors

  • María Ana Martínez Castellanos Department of Ophthalmology, Asociación para Evitar la Ceguera en México, Hospital “Luis Sanchez Bulnes” I.A.P., Mexico City, Mexico PubMed articlesGoogle scholar articles
  • Shulamit Schwartz Department of Ophthalmology, Denver Health Medical Center, Affiliated with University of Colorado, Denver, Colorado, USA PubMed articlesGoogle scholar articles
  • Gerardo García-Aguirre Department of Ophthalmology, Asociación para Evitar la Ceguera en México, Hospital “Luis Sanchez Bulnes” I.A.P., Mexico City, Mexico PubMed articlesGoogle scholar articles
  • Hugo Quiroz-Mercado Department of Ophthalmology, Denver Health Medical Center, Affiliated with University of Colorado, Denver, Colorado, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Shulamit Schwartz, Department of Ophthalmology, Denver Health Medical Center, Affiliated with University of Colorado, 6740 unit A, E. Cedar Ave., Denver, CO 80224, USA; schwartz330{at}gmail.com
View Full Text

Citation

Castellanos MAM, Schwartz S, García-Aguirre G, et al
Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity

Publication history

  • Received June 28, 2012
  • Revised October 19, 2012
  • Accepted November 7, 2012
  • First published December 8, 2012.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.